In addition to chronic lung infections, what is a significant risk factor for patients with cystic fibrosis?

Cystic fibrosis (CF) is a genetic disorder that primarily affects the lungs and the digestive system. One of the significant complications associated with CF is the development of diabetes. This condition, often referred to as cystic fibrosis-related diabetes (CFRD), occurs due to damage to the pancreas, which is responsible for insulin production. As the disease progresses, the thick mucus characteristic of CF can obstruct the pancreatic ducts, leading to insufficient insulin production and impaired glucose metabolism.

The prevalence of diabetes in patients with cystic fibrosis is notably higher than in the general population, making it a critical risk factor to consider in their overall health management. Monitoring blood glucose levels and considering lifestyle interventions or insulin therapy is vital for these patients to manage their diabetes effectively and maintain better overall health.

In contrast, while pneumothorax, cardiac issues, and malnutrition are also potential concerns for patients with cystic fibrosis, they do not occur as universally or significantly as diabetes does. For instance, while the risk of pneumothorax can increase due to lung damage, it is not as directly related to the genetic and metabolic dysfunctions caused by CF. Similarly, cardiac issues can arise but are often secondary to the complications of respiratory disease rather than a direct result of